|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
2,3-Dinor 11 Beta-Prostaglandin F2 Alpha, Random, Urine
Test Code10041
CPT Codes
84150, 82570
Preferred Specimen
5 mL random urine collected in a plastic 5 mL tube (T465)
Patient Preparation
Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAID) may have decreased concentrations of prostaglandin F2 alpha. If possible, discontinue for 2 weeks or 72 hours, respectively, prior to collecting a specimen.
Minimum Volume
4 mL
Instructions
Patient Preparation: Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAID) may have decreased concentrations of prostaglandin F2 alpha. If possible, discontinue for 2 weeks or 72 hours, respectively, prior to collecting a specimen.
Transport Container
Plastic 5 mL tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 8 hours
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Methodology
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) • Enzymatic Colorimetric Assay
FDA Status
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.
Setup Schedule
Monday, Thursday Morning
Report available: 2 Days
Report available: 2 Days
Reference Range
See Laboratory Report
Clinical Significance
Screening for mast cell activation disorders including systemic mastocytosis using random urine specimens.
